European Medicines Agency
AI overview
Sign in and the AI will write an overview from our coverage.
Headlines · 1
- AI Drug Discovery Enters Its Validation Era
IT时报 reports that AI drug discovery is shifting from the speed of generating candidate molecules toward laboratory validation, clinical value, data governance, and regulation. At a forum in Shanghai, deputy director Li Xiangyu of the Shanghai Center for Drug Evaluation described the field as entering a “clinical-first, value-first” stage, while industry executives described the dry-lab and wet-lab validation gap, data scarcity, and the need for human oversight.
虎嗅 AI · 🔥 0
Experience and discussion from the community
Share my European Medicines Agency experienceAsk about European Medicines Agency
Nobody has shared their experience with European Medicines Agency yet.